CF
IOVA icon

CNA Financial’s Iovance Biotherapeutics IOVA Stock Holding History

CNA Financial’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,136
Closed -$353K – 202
2021
Q1 		$353K Buy
11,136
+3,910
+54% +$162K 0.11% 184
2020
Q4 		$335K Sell
7,226
-3,320
-31% -$132K 0.11% 181
2020
Q3 		$347K Sell
10,546
-2,810
-21% -$86.1K 0.13% 161
2020
Q2 		$367K Buy
+13,356
New +$439K 0.15% 155

Other funds holding IOVA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

CNA Financial's IOVA Position: Q2 2021 in Review

CNA Financial sold out of Iovance Biotherapeutics (IOVA) in Q2 2021, closing a stake of 11,136 shares — an estimated $353K sold.

CNA Financial first reported a position in IOVA in Q2 2020 and held it in 4 quarters. The position peaked at $367K in Q2 2020. 234 funds tracked by Wall St. Rank hold IOVA as of Q2 2021.

  • CNA Financial reported no remaining Iovance Biotherapeutics position as of Q2 2021 after selling out during the quarter.
  • CNA Financial sold 11,136 Iovance Biotherapeutics shares in Q2 2021, an estimated $353K.
  • CNA Financial first reported a position in Iovance Biotherapeutics in Q2 2020 and held it in 4 quarters.
  • CNA Financial's Iovance Biotherapeutics position peaked at $367K in Q2 2020.
  • 234 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2021.

Based on CNA Financial's 13F filing for Q2 2021, filed 12 Aug 2021.